Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 2536 AL 2550

Disentangling Mitochondria in Alzheimer's Disease

Johri A.

Int J Mol Sci. 2021 Oct 26;22(21):11520. doi: 10.3390/ijms222111520.

Alzheimer's Disease and Diabetes Mellitus in Comparison: The Therapeutic Efficacy of the Vanadium Compound

He Z, You G, Liu Q, Li N.

Int J Mol Sci. 2021 Nov 3;22(21):11931. doi: 10.3390/ijms222111931.

Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer's Disease

Friedli MJ, Inestrosa NC.

Molecules. 2021 Oct 29;26(21):6531. doi: 10.3390/molecules26216531.

Antisense oligonucleotides for Alzheimer's disease therapy: from the mRNA to miRNA paradigm

Grabowska-Pyrzewicz W, Want A, Leszek J, Wojda U.

EBioMedicine. 2021 Dec;74:103691. doi: 10.1016/j.ebiom.2021.103691. Epub 2021 Nov 10.

Formaldehyde toxicity in age-related neurological dementia

Kou Y, Zhao H, Cui D, Han H, Tong Z.

Ageing Res Rev. 2022 Jan;73:101512. doi: 10.1016/j.arr.2021.101512. Epub 2021 Nov 17.

Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer's disease

Dhapola R, Hota SS, Sarma P, Bhattacharyya A, Medhi B, Reddy DH.

Inflammopharmacology. 2021 Dec;29(6):1669-1681. doi: 10.1007/s10787-021-00889-6. Epub 2021 Nov 23.

Alzheimer Disease and Sleep Disorders: Insights into the Possible Disease Connections and the Potential Therapeutic Targets (Part I)

Bahbah EI, Kamal MA.

CNS Neurol Disord Drug Targets. 2021;20(7):572-573. doi: 10.2174/187152732007210909150558.

Advanced Nanoparticular Approaches to Combat Alzheimer's Disease

Shah R, Bhattacharya S.

Pharm Nanotechnol. 2021;9(5):308-316. doi: 10.2174/2211738509666211123091913.

Harnessing cerebral organoids for Alzheimer's disease research

Bubnys A, Tsai LH.

Curr Opin Neurobiol. 2022 Feb;72:120-130. doi: 10.1016/j.conb.2021.10.003. Epub 2021 Nov 21.

Pharmacological Medical Treatment of Epilepsy in Patients with Dementia: A Systematic Review

Musaeus CS, Nilsson C, Cooper C, Kramberger MG, Verdelho A, Stefanova E, Religa D, Waldemar G, Frederiksen KS.

Curr Alzheimer Res. 2021;18(9):689-694. doi: 10.2174/1567205018666211126121529.

Therapeutic potential of neurotrophic factors in Alzheimer's Disease

Nasrolahi A, Javaherforooshzadeh F, Jafarzadeh-Gharehziaaddin M, Mahmoudi J, Asl KD, Shabani Z.

Mol Biol Rep. 2022 Mar;49(3):2345-2357. doi: 10.1007/s11033-021-06968-9. Epub 2021 Nov 26.

Significance of GABA(A) Receptor for Cognitive Function and Hippocampal Pathology

Sakimoto Y, Oo PM, Goshima M, Kanehisa I, Tsukada Y, Mitsushima D.

Int J Mol Sci. 2021 Nov 18;22(22):12456. doi: 10.3390/ijms222212456.

Therapeutic Potential of Mitophagy-Inducing Microflora Metabolite, Urolithin A for Alzheimer's Disease

Jayatunga DPW, Hone E, Khaira H, Lunelli T, Singh H, Guillemin GJ, Fernando B, Garg ML, Verdile G, Martins RN.

Nutrients. 2021 Oct 23;13(11):3744. doi: 10.3390/nu13113744.

Alzheimer Disease and Sleep Disorders: Insights into the Possible Disease Connections and the Potential Therapeutic Targets (Part II)

Kamal MA, Bahbah EI.

CNS Neurol Disord Drug Targets. 2021;20(8):674-676. doi: 10.2174/187152732008210921121240.

Impact of Donepezil and Memantine on Behavioral and Psychological Symptoms of Alzheimer Disease: Six-month Open-label Study

Bago Rožanković P, Rožanković M, Badžak J, Stojić M, Šušak Sporiš I.

Cogn Behav Neurol. 2021 Dec 2;34(4):288-294. doi: 10.1097/WNN.0000000000000285.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias